Deutsche Bank's recent analysis shows the 'Sell in May and go away' strategy offers no consistent advantage over buy-and-hold investing. While it appears profitable on average since 1987, this is mainly due to three exceptional years (1998, 2001, 2002) when markets fell sharply in summer. Excluding these years, the strategy underperforms in most cases, including the past decade. Even a bond-enhanced version only marginally improves results and still lacks reliability. Deutsche Bank advises investors to ignore calendar-based rules and focus on market fundamentals instead.
A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
California American Water and Sonoma County Fire District completed projects reducing wildfire risk around water facilities in Sonoma County. The efforts included clearing flammable vegetation near critical infrastructure like water storage tanks and...
